New insights are enhancing scientists' efforts to stay ahead of COVID-19 and the next pandemic.
Unexpected new insights into the ways COVID-19 infects cells could shed light on the virus's adept ability to jump from one species to another and assist scientists in more accurately predicting its evolution.
The pandemic has been marked by extensive debate regarding the mechanism by which COVID-19 invades cells, largely focusing on its use of a human cell protein known as ACE2. However, recent research from the University of Virginia School of Medicine reveals that ACE2 isn't required for infection. Instead, the virus has other means it can use to infect cells.
That versatility suggests that coronaviruses can use multiple "doors" to enter cells, potentially explaining how they are so good at infecting different species.

Researcher Peter Kasson, MD, PhD, of the University of Virginia School of Medicine. Credit: UVA Health
Understanding COVID-19
COVID-19 has killed almost 7 million people around the world. Thankfully, the availability of vaccines and the increase in population immunity means that the virus is no longer the threat it once was to most people (though it remains a concern for groups such as the immunocompromised and elderly). With the expiration of the United States' official Public Health Emergency in May, most Americans have largely returned to lives similar to the ones they knew before the pandemic emerged in 2019. But COVID-19 continues to evolve and change, and scientists are keeping a close eye on it so that they can take quick action if a more dangerous variant emerges. They also continue to monitor other coronaviruses in case they jump to humans and become the next great public health threat.
As part of this effort, Kasson and his team wanted to better understand how the virus responsible for COVID-19, SARS-CoV-2, can enter human cells. Scientists have known that the virus essentially knocks on the cell's door by binding to ACE2 proteins. These proteins are bountiful on the surfaces of cells lining the nose and lungs.
SARS-CoV-2 can also bind with other proteins, however. Was it possible, the scientists wondered, that it could use those other proteins to infiltrate cells? The answer was yes. ACE-2 was the most efficient route, but it was not the only route. And that suggests that the virus can bind and infect even cells without any ACE-2 receptors at all.
That unexpected finding may help explain why coronaviruses are so adept at species-hopping, Kasson says. And that makes it even more important that scientists keep a close eye on them, he notes.
"Coronaviruses like SARS-CoV-2 have already caused one pandemic and several near misses that we know of," he said. "That suggests there are more out there, and we need to learn how they spread and what to watch out for."
Reference: "The ACE2 receptor accelerates but is not biochemically required for SARS-CoV-2 membrane fusion" by Marcos Cervantes, Tobin Hess, Giorgio G. Morbioli, Anjali Sengara and Peter M. Kasson, 5 June 2023, Chemical Science.
DOI: 10.1039/D2SC06967A
The study was funded by the Commonwealth Health Research Board, grant 207-01-18; UVA's Global Infectious Diseases Institute; and the Knut and Alice Wallenberg Foundation, grant KAW2020.0209.
News
Molecular Manufacturing: The Future of Nanomedicine – New book from Frank Boehm
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
New Book! NanoMedical Brain/Cloud Interface – Explorations and Implications
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence
A new book by Frank Boehm, NanoappsMedical Inc. Founder. This groundbreaking volume explores the vision of a Global Health Care Equivalency (GHCE) system powered by artificial intelligence and quantum computing technologies, operating on secure [...]
Miller School Researchers Pioneer Nanovanilloid-Based Brain Cooling for Traumatic Injury
A multidisciplinary team at the University of Miami Miller School of Medicine has developed a breakthrough nanodrug platform that may prove beneficial for rapid, targeted therapeutic hypothermia after traumatic brain injury (TBI). Their work, published in ACS [...]
COVID-19 still claims more than 100,000 US lives each year
Centers for Disease Control and Prevention researchers report national estimates of 43.6 million COVID-19-associated illnesses and 101,300 deaths in the US during October 2022 to September 2023, plus 33.0 million illnesses and 100,800 deaths [...]
Nanomedicine in 2026: Experts Predict the Year Ahead
Progress in nanomedicine is almost as fast as the science is small. Over the last year, we've seen an abundance of headlines covering medical R&D at the nanoscale: polymer-coated nanoparticles targeting ovarian cancer, Albumin recruiting nanoparticles for [...]
Lipid nanoparticles could unlock access for millions of autoimmune patients
Capstan Therapeutics scientists demonstrate that lipid nanoparticles can engineer CAR T cells within the body without laboratory cell manufacturing and ex vivo expansion. The method using targeted lipid nanoparticles (tLNPs) is designed to deliver [...]
The Brain’s Strange Way of Computing Could Explain Consciousness
Consciousness may emerge not from code, but from the way living brains physically compute. Discussions about consciousness often stall between two deeply rooted viewpoints. One is computational functionalism, which holds that cognition can be [...]
First breathing ‘lung-on-chip’ developed using genetically identical cells
Researchers at the Francis Crick Institute and AlveoliX have developed the first human lung-on-chip model using stem cells taken from only one person. These chips simulate breathing motions and lung disease in an individual, [...]
Cell Membranes May Act Like Tiny Power Generators
Living cells may generate electricity through the natural motion of their membranes. These fast electrical signals could play a role in how cells communicate and sense their surroundings. Scientists have proposed a new theoretical [...]
This Viral RNA Structure Could Lead to a Universal Antiviral Drug
Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for enteroviruses. A new study from the University of Maryland, Baltimore County (UMBC), published in Nature Communications, explains how enteroviruses begin reproducing [...]
New study suggests a way to rejuvenate the immune system
Stimulating the liver to produce some of the signals of the thymus can reverse age-related declines in T-cell populations and enhance response to vaccination. As people age, their immune system function declines. T cell [...]
Nerve Damage Can Disrupt Immunity Across the Entire Body
A single nerve injury can quietly reshape the immune system across the entire body. Preclinical research from McGill University suggests that nerve injuries may lead to long-lasting changes in the immune system, and these [...]
Fake Science Is Growing Faster Than Legitimate Research, New Study Warns
New research reveals organized networks linking paper mills, intermediaries, and compromised academic journals Organized scientific fraud is becoming increasingly common, ranging from fabricated research to the buying and selling of authorship and citations, according [...]
Scientists Unlock a New Way to Hear the Brain’s Hidden Language
Scientists can finally hear the brain’s quietest messages—unlocking the hidden code behind how neurons think, decide, and remember. Scientists have created a new protein that can capture the incoming chemical signals received by brain [...]
Does being infected or vaccinated first influence COVID-19 immunity?
A new study analyzing the immune response to COVID-19 in a Catalan cohort of health workers sheds light on an important question: does it matter whether a person was first infected or first vaccinated? [...]















